The Latest Breaking News from Acharya Balkrishna

A research paper published on Patanjali’s Renogrit, a formulation that is effective against cancer drug cisplatin’s damaging effect on kidneys, has been featured among the most notable research studies of 2024. The study titled Renogrit selectively protects against cisplatin‑induced injury in human renal tubular cells and in Caenorhabditis elegans by…

The Supreme Court has dropped the contempt of court charges against Patanjali Ayurved and its founders Baba Ramdev and Acharya Balkrishna, Bar and Bench reported.

Yoga guru Baba Ramdev and Patanjali Ayurved's Managing Director Acharya Balkrishna arrived at the Supreme Court. Read further on Dynamite News:

Patanjali misleading ads case: Yoga guru Ramdev, Patanjali Ayurved MD Acharya Balkrishna appear in Supreme Court

The Bench also issued a contempt notice against the company and its Managing Director Acharya Balkrishna for failing to adhere to directions passed in November last year. The “entire country has been taken for a ride”, the Bench said, while reprimanding the Union Government for its failure to take “urgent…

This NL Sena project is still to be topped up. Contribute to the fund and pay to keep news free. Contribute now.

NAGPUR: Patanjali Ayurved, which has acquired 230 acres land in the domestic tariff area (DTA) of Mihan project six years ago, has once again assured to start production at its unit in Nagpur soon.